In the current study, anti-HMGB1 treatment did not affect circulating levels of inflammatory cytokines induced by PbA infection, although the same antibody has been shown to attenuate levels of inflammatory cytokines induced by CLP in an experimental sepsis model[8]. The gene discussed is HMGB1; the disease is infection.